Concepedia

Emily A. Pace

EA

Statistics

Publications

9

Citations

985

H-Index

9

Active since

2001

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

Boston University

Harvard University

Emily A. Pace is an author at Merrimack Pharmaceuticals (United States) specializing in cell signaling, signal transduction, and life sciences.

Publications per year

2001–2018

9

Publications

9

Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis

Birgit Schoeberl, Emily A. Pace, Jonathan B. Fitzgerald et al. · Science Signaling · 2009 · 368 citations

, , +17

A Compendium of Signals and Responses Triggered by Prodeath and Prosurvival Cytokines

Suzanne Gaudet, Kevin A. Janes, John G. Albeck et al. · Molecular & Cellular Proteomics · 2005 · 161 citations · Full text

, , +17

Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines

Mario Niepel, Marc Hafner, Emily A. Pace et al. · Science Signaling · 2013 · 103 citations

, , +17

Inhibition of transcription factor NF-κB signaling proteins IKKβ and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity

Mei‐Chih Liang, Sujata Bardhan, Emily A. Pace et al. · Biochemical Pharmacology · 2005 · 83 citations

, , +10

Angiogenesis Inhibitor Epoxyquinol A:  Total Synthesis and Inhibition of Transcription Factor NF-κB

Chaomin Li, Sujata Bardhan, Emily A. Pace et al. · Organic Letters · 2002 · 70 citations

, , +10

1–5 of 9